[HTML][HTML] A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality
RK Wadhera, DL Steen, I Khan, RP Giugliano… - Journal of clinical …, 2016 - Elsevier
Cardiovascular (CV) disease is a leading cause of death worldwide, accounting for
approximately 31.4% of deaths globally in 2012. It is estimated that, from 1980 to 2000 …
approximately 31.4% of deaths globally in 2012. It is estimated that, from 1980 to 2000 …
National trends in statin use and expenditures in the US adult population from 2002 to 2013: insights from the medical expenditure panel survey
Importance Statins remain a mainstay in the prevention and treatment of atherosclerotic
cardiovascular disease (ASCVD). Objective To detail the trends in use and total and out-of …
cardiovascular disease (ASCVD). Objective To detail the trends in use and total and out-of …
Management of LDL‐cholesterol after an acute coronary syndrome: Key comparisons of the American and European clinical guidelines to the attention of the …
B Gencer, RP Giugliano - Clinical Cardiology, 2020 - Wiley Online Library
Guidelines for the management of blood cholesterol were updated in the past year in the
United States and Europe, reflecting a more intensive approach to lowering low‐density …
United States and Europe, reflecting a more intensive approach to lowering low‐density …
[HTML][HTML] Use of lipid-modifying therapy and LDL-C goal attainment in a high-cardiovascular-risk population in the Netherlands
JG Kuiper, RJ Sanchez, E Houben, EM Heintjes… - Clinical Therapeutics, 2017 - Elsevier
Purpose This study investigates lipid-modifying therapy (LMT) and LDL-C goal attainment in
a real-world, high-cardiovascular-risk population in the Netherlands. Methods From the …
a real-world, high-cardiovascular-risk population in the Netherlands. Methods From the …
Patterns and predictors of lipid‐lowering therapy in patients with atherosclerotic cardiovascular disease and/or diabetes mellitus in 2014: insights from a large US …
DL Steen, I Khan, L Becker, JAM Foody… - Clinical …, 2017 - Wiley Online Library
Background Lowering low‐density lipoprotein cholesterol with statins reduces risk of
cardiovascular events. We examined patterns and predictors of filled prescriptions for lipid …
cardiovascular events. We examined patterns and predictors of filled prescriptions for lipid …
Recurrent atherosclerotic cardiovascular disease events potentially prevented with guideline-recommended cholesterol-lowering therapy following myocardial …
S Sakhuja, VA Bittner, TM Brown, ME Farkouh… - … Drugs and Therapy, 2024 - Springer
Purpose Many adults with atherosclerotic cardiovascular disease (ASCVD) who are
recommended to take a statin, ezetimibe and/or a proprotein convertase subtilisin/kexin type …
recommended to take a statin, ezetimibe and/or a proprotein convertase subtilisin/kexin type …
Temporal trends of high‐intensity statin therapy among veterans treated with percutaneous coronary intervention
AA Bin Abdulhak, M Vaughan‐Sarrzin… - Journal of the …, 2018 - Am Heart Assoc
Background The 2013 American College of Cardiology/American Heart Association blood
cholesterol guideline recommends high‐intensity statin therapy among certain groups of …
cholesterol guideline recommends high‐intensity statin therapy among certain groups of …
Cardiovascular risk factor burden in people with incident type 2 diabetes in the US receiving antidiabetic and cardioprotective therapies
O Montvida, X Cai, SK Paul - Diabetes Care, 2019 - Am Diabetes Assoc
OBJECTIVE Individualized treatment of patients with diabetes requires detailed evaluation
of risk factor dynamics at the population level. This study evaluated the persistent glycemic …
of risk factor dynamics at the population level. This study evaluated the persistent glycemic …
Exploring Contemporary Data on Lipid-Lowering Therapy Prescribing in Patients Following Discharge for Atherosclerotic Cardiovascular Disease in the South of Italy
A Citarella, S Cammarota, FF Bernardi… - Journal of Clinical …, 2022 - mdpi.com
Current international guidelines strongly recommend the use of high-intensity lipid-lowering
therapy (LLT) after hospitalization for atherosclerotic cardiovascular disease (ASCVD) …
therapy (LLT) after hospitalization for atherosclerotic cardiovascular disease (ASCVD) …
Impact of prior chronic statin therapy and high-intensity statin therapy at discharge on circulating endothelial progenitor cell levels in patients with acute myocardial …
N António, R Fernandes, A Soares, F Soares… - European journal of …, 2014 - Springer
Background Endothelial progenitor stem cells (EPCs) are mobilized to the peripheral
circulation in response to myocardial ischemia, playing a crucial role in vascular repair …
circulation in response to myocardial ischemia, playing a crucial role in vascular repair …